Saltagen Ventures

Fano Labs is an artificial intelligence company based in Shatin, Hong Kong, specializing in speech recognition and natural language processing technologies. Founded in 2015, the company focuses on developing solutions that enable the processing and analysis of various Chinese dialects, particularly Cantonese, as well as other Southeast Asian languages. Fano Labs serves a diverse range of sectors, including customer service, compliance, and operational efficiency for enterprises such as global banks, government agencies, and telecom companies. Their advanced AI technologies enhance management capabilities and service quality by accurately identifying compliance risks and analyzing customer sentiment. By providing valuable business intelligence, Fano Labs helps organizations reduce costs and uncover sales opportunities, ultimately driving revenue growth.

Beatdapp is a music technology company that specializes in streaming fraud detection and royalty tracking for artists and music labels. Founded in 2018 and headquartered in Vancouver, B.C., with additional offices in Los Angeles and Toronto, Beatdapp aims to eliminate streaming fraud and ensure fair compensation for creators. The company's software provides real-time authentication and verification of music streams, addressing discrepancies between Digital Service Providers and rights holders. This innovative approach enhances the accuracy and transparency of streaming data, thereby increasing royalty revenue for artists while reducing potential legal issues related to royalties. With a team of industry and technology veterans, Beatdapp is positioned to significantly impact the music industry, which is projected to grow substantially in the coming years.

Child Health Imprints specializes in improving neonatal intensive care worldwide by developing advanced informational and computational technologies. Their core product is a cloud-based NICU platform that integrates laboratory results with real-time data analytics, utilizing machine learning to aid clinicians in monitoring and treating high-risk newborns. The company aims to enhance early disease diagnosis and overall healthcare quality for neonates through these innovative tools.

Sympatic is a technology company that specializes in secure data sharing and access solutions. It enables owners and users of sensitive data to collaborate and extract value without compromising the integrity of their data or intellectual property. By creating temporary, secure computing environments in the cloud, Sympatic allows algorithms to interact with data safely and efficiently. This technology facilitates controlled access to data for analysis and collaboration with third parties while ensuring that data owners retain full control. Sympatic's innovative approach simplifies the complexities of cloud operations, making it accessible for users who may not have expertise in advanced cloud DevOps, thus optimizing the value derived from sensitive information without the risk of data leakage or loss.

Oncoustics is a company focused on enhancing clinical workflow through advanced artificial intelligence solutions aimed at non-invasive surveillance, diagnostics, and treatment monitoring of diseases with significant unmet clinical needs. Unlike competitors that rely on image recognition, Oncoustics utilizes AI to analyze raw ultrasound signals from readily available handheld devices, allowing for the rapid differentiation between healthy and diseased tissues. This innovative approach uncovers novel acoustic biomarkers that align with existing medical standards. Initially concentrating on liver disease, a market valued at $30 billion, Oncoustics has sought Breakthrough Device Designation from the FDA for its OnX system, designed to detect liver fibrosis, with further regulatory submissions underway. The company is also developing additional liver-related products and possesses clinical data for applications in various other organ conditions, including prostate, kidney, breast, and thyroid diseases and cancers.

CaroMeats grows healthy, delicious meat directly from animal cells. No environmental damage is caused. No animals are harmed.

PulseMedica is an Edmonton-based medical device startup focused on developing an innovative ophthalmic platform for non-invasive, automated laser treatment of vitreoretinal diseases. Utilizing advanced 3D computer vision, real-time tracking, and femtosecond laser technology, the company aims to enhance the quality of life for millions by providing effective screening and treatment options for conditions such as age-related macular degeneration, diabetic retinopathy, branch retinal vein occlusion, and glaucoma. PulseMedica's short-term goal is to establish itself as a global leader in the non-invasive treatment of eye floaters, while its long-term vision seeks to set the standard for the screening and treatment of vitreoretinal diseases worldwide. Through the integration of machine learning and sophisticated imaging technology, PulseMedica endeavors to facilitate timely diagnoses and improve therapeutic outcomes for patients suffering from retinal disorders.

Modl.ai is a technology company focused on revolutionizing game development through the application of artificial intelligence and machine learning. By providing a platform that streamlines the production process, Modl.ai empowers game developers and publishers to automate repetitive tasks and create more advanced in-game behaviors and simulations. This innovative approach enhances the overall quality of games, improves user experiences, and increases operational efficiency for its clients. With a commitment to advancing game technology, Modl.ai aims to accelerate game development and boost player engagement globally.

Juno Diagnostics, Inc. is a health technology company based in San Diego, California, founded in 2017. The company specializes in developing cell-free DNA-based noninvasive prenatal testing, providing women and their healthcare providers with crucial genetic information. Juno Diagnostics aims to democratize access to high-value genetic data by creating simple and cost-effective testing devices that facilitate point-of-need genetic testing. Their innovative technology enhances sample collection and delivers high-quality test results without the need for traditional phlebotomy procedures, thus reducing costs and lead times associated with genetic testing. Additionally, Juno is involved in the development of genetic testing tools for applications in epigenetics, inherited diseases, and cancer diagnostics.

Sanctuary AI, founded in January 2018 and based in Vancouver, Canada, is focused on developing synthetic humans, referred to as "synths." The company's mission is to create robots that are indistinguishable from humans in physical appearance, cognitive abilities, and emotional responses. In addition to advancing cutting-edge technology, Sanctuary AI is committed to addressing the ethical implications associated with the creation of human-like machines.

CocoRobo Ltd., established in Hong Kong in 2016, specializes in designing comprehensive educational solutions for Science, Technology, Engineering, Arts, and Mathematics (STEAM). The company offers a range of software and hardware products, including electronic modules, course kits, 3D printers, and printing supplies. Its platform provides teaching content and services, enabling students to develop creative skills and build unique electronic projects such as robots or smart home devices.

Black.ai is an Australian company based in Fitzroy, established in 2017. It specializes in developing an autonomous retail platform that utilizes artificial intelligence and multi-dimensional sensors to map stores in real-time. The platform monitors human behavior, automates the observation of people's movements, and detects notable events such as theft or stock interactions. This enables large format retailers to make real-time decisions, enhance staff response, prevent theft, and manage inventory more effectively.

Cathay Photonics Limited is a Hong Kong-based company founded in 2014 that specializes in the research, development, and commercialization of specialty-coated glass and ceramic products tailored for the photonics and optoelectronics industries. The company focuses on providing advanced technologies and solutions, notably in the fabrication of ultra-hard protective films applied to transparent substrates. These coatings are primarily used in the cover-glass of electronic devices, including monitors, tablets, and smartphones. Through its innovative offerings, Cathay Photonics aims to enhance the durability and performance of consumer electronics while supporting efficient manufacturing processes in its sector.

HelpWear Inc. is a Canadian company based in Toronto, founded in 2015, that focuses on enhancing at-home healthcare through innovative wearable technology. The company develops an affordable and accessible heart monitoring device designed to detect heart attacks and provide real-time alerts to emergency medical services. This waterproof device not only stores vital cardiovascular data but also features an embedded emergency contact system, ensuring that patients with heart ailments can receive timely assistance and maintain communication with healthcare providers regarding their health status. HelpWear's approach emphasizes clinical need-driven innovation, aiming to address both patient requirements and the demands of the healthcare system.

HelpWear Inc. is a Canadian company based in Toronto, founded in 2015, that focuses on enhancing at-home healthcare through innovative wearable technology. The company develops an affordable and accessible heart monitoring device designed to detect heart attacks and provide real-time alerts to emergency medical services. This waterproof device not only stores vital cardiovascular data but also features an embedded emergency contact system, ensuring that patients with heart ailments can receive timely assistance and maintain communication with healthcare providers regarding their health status. HelpWear's approach emphasizes clinical need-driven innovation, aiming to address both patient requirements and the demands of the healthcare system.